Navigation Links
Leeds researchers test benefit of fish oil in bowel cancer spread

Researchers from the University of Leeds will carry out a series of experiments to see whether fish oil can prevent or treat the spread of bowel cancer to the liver.

The cancer scientists will test the effectiveness of pure Eicosapentaenoic Acid (EPA) - a naturally occurring omega-3 fish oil component which is widely available in mixed fish oil preparations in health stores and supermarkets nationwide.

Gastroenterologist Professor Mark Hull, based at the Leeds Institute of Molecular Medicine, University of Leeds, will use results from the initial experiments to design a future clinical trial to test the effect of pure EPA in humans at risk of or with metastatic bowel cancer.

The research is being funded by Yorkshire Cancer Research and it will hopefully back up existing evidence from a previous clinical trial from Leeds that showed that EPA may prevent large bowel polyps, the benign precursors of large bowel cancer.

"We and others have already demonstrated that EPA might have beneficial effects at a later stage after development of malignancy," said Professor Hull.

"These new tests will help us establish whether EPA can prevent the spread of large bowel cancer to the liver, the commonest site of spread and eventual cancer-related death which we call metastasis.

"The tests will also help us establish how EPA reduces growth of established liver metastases in an experimental system prior to design of the clinical trial."

The trial published last year, which involved 55 patients with the rare inherited condition Familial Adenomatous Polyposis (FAP) thought to be responsible for about one in every 100 bowel cancers, saw a significant reduction in the size and number of pre-cancerous growths, known as polyps, in those patients who took a two gram daily dose of EPA in the free fatty acid form over a six month period.

Another promising study currently being led by the Leeds team involving nearly a 1000 patients, is investigating whether taking EPA alone, or together with aspirin, can help stop pre-cancerous growths from developing in the bowel.


Contact: Paula Gould
University of Leeds

Related medicine news :

1. Leeds Teaching Hospitals Trust and RSLSteeper Team Up to Help Paralympian Walk His Sister Down the Aisle
2. Fox Chase researchers identify new mechanism used by cells to reverse silenced genes
3. BUSM researchers find herbal medicine treatment reduces inflammation in allergen-induced asthma
4. Researchers at Oregon Health & Science University discover MS-like disease in monkeys
5. Drug shows improved kidney function for type 2 diabetics, UT Southwestern researchers report
6. Researchers identify components of speech recognition pathway in humans
7. Wayne State University researchers win grant from the NSF to target tinnitus
8. Researchers find CDT biomarker ineffective for identifying unhealthy alcohol use
9. Mayo Clinic researchers use human vaccine to cure prostate cancer in mice
10. UT Southwestern researchers uncover why ketamine produces a fast antidepressant response
11. Researchers report progress using iPS cells to reverse blindness
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... An inventor, ... to dispense prescription medications at home, so he invented the patent-pending ELECTRONIC M.D. ... dispense prescription medications. In doing so, it could help to prevent potential overdose ...
(Date:11/27/2015)... ... ... No.1 Herpes-only dating community in the world, revealed that over 50% of its members are ... people under the age of 50 – or 67% of the population - are infected ... HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder of ...
(Date:11/27/2015)... ... November 27, 2015 , ... Keeping ... platform for mental health and wellness consultation, has collaborated with a leading web-based ... the knowledge gap experienced by parents and bring advice from parenting experts within ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... contact center software Q-Suite, announces the incorporation of Asterisk 11 LTS (Long Term ... fully supported Asterisk 11 LTS brings Q-Suite 5.10 up-to-date with a version of ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent Applied Drug ... need to integrate dose form selection in early phase drug development. The first ... supporting and bringing together the UK’s emerging life sciences companies, corporate partners, and ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... 2015 ... "2016 Global Tumor Marker Testing Market: ... Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ... their offering. --> ) ... "2016 Global Tumor Marker Testing Market: Supplier ...
(Date:11/26/2015)... 2015 --> ... combineert immunotherapie met Bremachlorin-photodynamische therapie voor de ... ) --> ... ) Uit een ... (LUMC) blijkt dat ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
Breaking Medicine Technology: